Biodegradable hemostat market seen reaching $1.63 billion by 2030

The biodegradable hemostat market is projected to grow from $1.08 billion in 2026 to $1.63 billion by 2030, supported by rising surgical volumes, minimally invasive procedures and broader use of absorbable surgical products. North America held the largest regional share in 2025, while the latest report points to stronger demand across hospitals and ambulatory surgical centers.

Why it matters: - The biodegradable hemostat market is expanding as surgeons and hospitals look for products that stop bleeding without requiring later removal. - The shift matters because absorbable products can reduce follow-up procedures and lower the risk of post-operative complications. - The market outlook points to broader demand for safer surgical tools as procedure volumes rise worldwide.

What happened: - The Business Research Company released its Biodegradable Hemostat Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035. - The report projects the market will grow from $0.97 billion in 2025 to $1.08 billion in 2026. - The report forecasts the market will reach $1.63 billion by 2030. - The forecast implies a 10.8% CAGR through 2030.

The details: - The recent growth period was driven by dependence on traditional non-absorbable hemostats, rising surgical procedure volumes, stronger hospital infrastructure, greater awareness of blood loss management and adoption of basic wound care technologies. - Future growth is tied to polymer and biomaterial innovation, more minimally invasive surgeries, more trauma and emergency cases, broader regulatory approvals for biodegradable products and the spread of ambulatory surgical centers. - The report highlights growing preference for absorbable hemostats, biocompatible materials and products used in laparoscopic and trauma-related procedures. - Demand is also moving toward ready-to-use, user-friendly products. - A biodegradable hemostat is designed to accelerate clotting, then safely break down and be absorbed by the body over time. - These devices are built to avoid surgical removal after use and to reduce the risk of adverse reactions. - In January 2025, Intuitive Surgical reported that general surgery procedures outside the U.S. grew about 35% in 2024 after a 42% increase in 2023. - Colorectal surgeries drove the largest share of that volume growth in both years. - North America held the largest share of the biodegradable hemostat market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report package includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables. - The company also offers a free sample report and full report download through its website. - Download the free sample - View the full report

Between the lines: - The forecast suggests biodegradable hemostats are moving from a niche surgical aid toward broader mainstream use as absorbable materials improve. - Rising outpatient surgery capacity and more minimally invasive procedures should support adoption beyond traditional hospital settings. - The regional lead in North America indicates the market is still concentrated in advanced healthcare systems, even as other regions remain part of the growth story.

What's next: - The report points to continued gains through 2030 if regulatory approvals, biomaterial advances and surgical volumes keep rising. - Growth may be strongest in laparoscopic, trauma and ambulatory surgery settings where ease of use and no-removal products have the most practical value. - The market will likely be shaped by how quickly manufacturers can scale ready-to-use biodegradable options and secure additional approvals.